Rat alpha-fetoprotein: isolation, radioimmunoassay and fetal-maternal distribution during pregnancy.
A method is described for the isolation of mg quantities of two forms of rat alpha-fetoprotein (AFP) from amniotic fluid by preparative disc-gel column electrophoresis using a continuous elution system. AFP isolated by this method is suitable for use as an antigen, can be labelled for use in a radioimmunoassay and serves as a reference standard. The characteristics of a new antiserum to AFP are also described. The protocol for a radioimmunoassay is outlined which permits the measurement of AFP in several fetal-maternal physiological compartments throughout gestation. Levels of AFP in fetal liver and fetal plasma suggest that secretion of AFP from liver occurs soon after synthesis with minimal hepatic storage. The pattern for AFP in maternal serum parallels that observed in amniotic fluid and fluctuations in maternal serum levels of AFP appear to be buffered by AFP accumulation in amniotic fluid. Fetal clearance of AFP under normal conditions may be relatively constant from Days 11-20 of gestation since an amniotic fluid: maternal serum AFP ratio of 30:1 is maintained during this period.
D000653:Amniotic Fluid / Q000378:metabolism; D000818:Animals; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005326:Fetal Proteins / Q000378:metabolism*; D005333:Fetus / Q000378:metabolism*; D005865:Gestational Age; D008099:Liver / Q000196:embryology / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal; D011863:Radioimmunoassay; D051381:Rats; D000509:alpha-Fetoproteins / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*
D005326:Fetal Proteins; D000509:alpha-Fetoproteins